Directory
Cancer biotherapeutics
On this page:
Biologically based therapeutics, which include oncolytic viruses and immune cell therapies, are among the most promising cancer treatments to emerge over the last decade. While different biotherapeutics function in different ways, one thing they have in common is the ability to mobilize and activate the body's natural defence mechanisms (the immune system) to attack cancer cells. Researchers at The Ottawa Hospital are leading the way in this area of research, with a number of world-first clinical trials and projects.
Research & News
Labs and Groups
These research teams may include multiple scientists, investigators, staff and trainees all working towards a common goal, or they can represent a single scientist and their team.
Research Group
Auer Lab
The Auer Lab makes use of both preclinical and clinical research to understand the mechanisms responsible for the prometastatic effects of surgery ...
Research Group
Bell Lab
Our research program is directed towards the identification and characterization of novel cancer killing therapeutic viruses that selectively infec...
Research Group
BMC VMF Group
Our group manufactures biologic or ‘living’ drugs, specifically virus-based therapies. The goal of the BMC-VMF is to provide our partners bo...
Research Group
Canadian-Led Immunotherapies Collaborative
CLIC brings researchers, clinicians and patients together to build Canadian expertise and capacity in cellular immunotherapy for cancer.
Research Group
Cook Lab
Treatment options for ovarian cancer are limited, and while tumours often respond to initial treatments, many recur and become resistant to therapy...
Research Group
Diallo Lab
Our research team is dedicated to exploring and advancing the field of "viral sensitizer" drugs, which enhance cellular susceptibility to viral m...
Research Group
Ilkow Lab
Findings from our research will provide new light on the role of the tumour microenvironment during virus-based therapies and could contribute to t...
Research Group
Vanderhyden Lab
Determining how risk factors contribute to ovarian cancer initiation and progression, single cell analyses and bioinformatics to investigat...
